nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A new microscopic insight into the thrombogenicity of umbilical catheters
|
Sobczak, Alina |
|
2018 |
168 |
C |
p. 80-82 |
artikel |
2 |
β-Antithrombin, subtype of antithrombin deficiency and the risk of venous thromboembolism in hereditary antithrombin deficiency: A family cohort study
|
Croles, Frederik Nanne |
|
2018 |
168 |
C |
p. 47-52 |
artikel |
3 |
Association of factor V activity with risk of venous thromboembolism and atherothrombotic cardiovascular events: A retrospective population-based cohort study
|
Saliba, Walid |
|
2018 |
168 |
C |
p. 14-19 |
artikel |
4 |
Benefits and risks of extended treatment of venous thromboembolism with rivaroxaban or with aspirin
|
Prandoni, Paolo |
|
2018 |
168 |
C |
p. 121-129 |
artikel |
5 |
Cytomegalovirus-associated splanchnic vein thrombosis in immunocompetent patients: A systematic review
|
Bertoni, Michele |
|
2018 |
168 |
C |
p. 104-113 |
artikel |
6 |
Dabigatran etexilate in the treatment of localized intravascular coagulopathy associated with venous malformations
|
Binet, Quentin |
|
2018 |
168 |
C |
p. 114-120 |
artikel |
7 |
Editorial Board
|
|
|
2018 |
168 |
C |
p. IFC |
artikel |
8 |
Effectiveness and safety of rivaroxaban versus warfarin in patients with unprovoked venous thromboembolism: A propensity-score weighted administrative claims cohort study
|
Coleman, Craig I. |
|
2018 |
168 |
C |
p. 31-36 |
artikel |
9 |
Electrocardiographic changes in pulmonary embolism: Each lead could be a clue in solving the puzzle
|
Scagliola, Riccardo |
|
2018 |
168 |
C |
p. 78-79 |
artikel |
10 |
Evaluation of the pulmonary embolism rule out criteria (PERC rule) in children evaluated for suspected pulmonary embolism
|
Kline, Jeffrey A. |
|
2018 |
168 |
C |
p. 1-4 |
artikel |
11 |
Fibrinolytic potential of DS-1040, a novel orally available inhibitor of activated thrombin-activatable fibrinolysis inhibitor (TAFIa)
|
Noguchi, Kengo |
|
2018 |
168 |
C |
p. 96-101 |
artikel |
12 |
Gender-related differences in post-discharge bleeding among patients with acute coronary syndrome on dual antiplatelet therapy: A BleeMACS sub-study
|
Grodecki, Kajetan |
|
2018 |
168 |
C |
p. 156-163 |
artikel |
13 |
Guidelines' risk assessment recommendations for venous thromboembolism prophylaxis: A comparison and implementability appraisal
|
Moesker, M.J. |
|
2018 |
168 |
C |
p. 5-13 |
artikel |
14 |
Phosphatidylserine expressing platelet microparticle levels at hospital presentation are decreased in sepsis non-survivors and correlate with thrombocytopenia
|
Puskarich, Michael A. |
|
2018 |
168 |
C |
p. 138-144 |
artikel |
15 |
Platelets and their Microparticles go hand in hand
|
Schwertz, Hansjörg |
|
2018 |
168 |
C |
p. 164-165 |
artikel |
16 |
Pleiotropic effects of n-6 and n-3 fatty acid-related genetic variants on circulating hemostatic variables
|
Weng, Lu-Chen |
|
2018 |
168 |
C |
p. 53-59 |
artikel |
17 |
Prevalence and in silico analysis of missense mutations in the PROS1 gene in the Swedish population: The SweGen dataset
|
Zöller, Bengt |
|
2018 |
168 |
C |
p. 28-30 |
artikel |
18 |
Protein S-specific activity assay system is not affected by direct oral anticoagulants
|
Kuma, Hiroyuki |
|
2018 |
168 |
C |
p. 60-62 |
artikel |
19 |
Prothrombotic mechanisms in patients with congenital p.Cys89Tyr mutation in CD59
|
Tabib, Adi |
|
2018 |
168 |
C |
p. 67-77 |
artikel |
20 |
Putative functional SNPs in SLC22A3 and H3F3B might influence the development of CAD by regulating the lipid levels
|
Mo, Xingbo |
|
2018 |
168 |
C |
p. 37-39 |
artikel |
21 |
Risk factors and obstetric outcomes in pregnancies complicated by pelvic vein thrombosis, and in the subsequent pregnancy
|
Bremme, Katarina |
|
2018 |
168 |
C |
p. 145-147 |
artikel |
22 |
Risk factors for inhibitor development in severe hemophilia A
|
Garagiola, Isabella |
|
2018 |
168 |
C |
p. 20-27 |
artikel |
23 |
Risk of venous thromboembolism events in postmenopausal women using oral versus non-oral hormone therapy: A systematic review and meta-analysis
|
Rovinski, Denise |
|
2018 |
168 |
C |
p. 83-95 |
artikel |
24 |
Sub therapeutic rivaroxaban plasma concentrations following administration via Percutaneous Endoscopic Gastrostomy (PEG) feeding tubes – A note of caution
|
Byrne, Rosalind |
|
2018 |
168 |
C |
p. 102-103 |
artikel |
25 |
Systematic review of risk prediction scores for venous thromboembolism following joint replacement
|
Kunutsor, Setor K. |
|
2018 |
168 |
C |
p. 148-155 |
artikel |
26 |
The DaXa-inhibition assay: A concept for a readily available, universal aXa assay that measures the direct inhibitory effect of all anti-Xa drugs
|
van Pelt, L.Joost |
|
2018 |
168 |
C |
p. 63-66 |
artikel |
27 |
The role of agonist-induced activation and inhibition for the regulation of purinergic receptor expression in human platelets
|
Koessler, Juergen |
|
2018 |
168 |
C |
p. 40-46 |
artikel |
28 |
Tissue factor (:Factor VIIa) in the heart and vasculature: More than an envelope
|
D'Alessandro, E. |
|
2018 |
168 |
C |
p. 130-137 |
artikel |